The Patented Medicine Prices Review Board (PMPRB) has announced that it intends to proceed to obtain ministerial and government approval of proposed amendments to the filing requirements under the Patented Medicines Regulations, 1994 which were published in the Canada Gazette, Part I on October 6, 2007. These changes, which will increase the filing requirements for patentees and shorten some of the time frames for filing, also include a controversial provision that would require patentees to identify the "type" of discount, rebate or other price concession included in the average price of the patented medicine. The Board has stated that it will provide information and advice to patentees on compliance with these changes should they come into effect.

For more information, please visit: